, Volume 35, Issue 7, pp 632–638 | Cite as

A genetic marker at the glucokinase gene locus for Type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles

  • K. C. Chiu
  • M. A. Province
  • G. K. Dowse
  • P. Z. Zimmet
  • G. Wagner
  • S. Serjeantson
  • M. A. Permutt


The prevalence of Type 2 (non-insulin-dependent) diabetes mellitus is high in Mauritius, a multiethnic island nation in the southwestern Indian Ocean. Evaluation of candidate genes in the different ethnic groups represents a means of assessing the genetic component. As glucokinase is known to be a key regulator of glucose homeostasis in liver and pancreatic Beta-cells, the human gene was isolated and a dinucleotide repeat (CA)n marker was identified at this locus. A polymerase chain reaction assay was developed, and alleles differing in size were observed in individuals, according to the number of repeats in the amplified fragment. Eighty-five Creoles and 63 Indians of known glucose tolerance status were typed by amplification of genomic DNA for this dinucleotide (CA)n repeat marker. Four different alleles were observed including Z, the most common allele, and Z+2, Z+4, and Z+10, which differed from Z by 2, 4, and 10 nucleotides respectively. In Mauritian Creoles, the frequency of the Z+2 allele was greater in Type 2 diabetic subjects than in control subjects (23.8 % vs 8.9 %, p=0.008), and the frequency of the Z allele was lower in Type 2 diabetic subjects (60% vs 75.6%, p=0.03). Analysis with univariate logistic regression models indicated that the Z+2 allele had the highest odds ratio, 3.08 (95% confidence interval 1.14–8.35, p=0.0416), among the other risk factors (age, sex, body mass index, and waist/hip ratio). The multivariate odds ratio for Type 2 diabetes was 2.88 (95% confidence interval 0.98–8.50, p=0.0551). In contrast, in the Mauritian Indian population, no differences were noted between the frequency of any glucokinase allele in the Type 2 diabetic and control groups. These data suggest that the Z+2 allele is an important risk factor for Type 2 diabetes in Mauritian Creoles, but not in Mauritian Indians, and also imply that the glucokinase gene may play a role in the pathogenesis of Type 2 diabetes in Mauritian Creoles. Further studies are needed to define the nature of this defect.

Key words

Type 2 (non-insulin-dependent) diabetes mellitus glucokinase population association study polymorphism dinucleotide (CA)n repeat obesity genetic 


  1. 1.
    Dowse GK, Gareeboo H, Zimmet PZ, etal. (1990) High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes 39: 390–396PubMedGoogle Scholar
  2. 2.
    Dowse GK, Gareeboo H, Zimmet PZ, et al. (1990) Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diab Dare 14: 271–282Google Scholar
  3. 3.
    McLarty DG, Pollitt C, Swai ASM (1990) Diabetes in Africa. Diabetic Med 7: 670–684PubMedGoogle Scholar
  4. 4.
    Ahuja MMS (1979) Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS (ed) Epidemiology of diabetes in developing countries. Interprint, New Delhi, pp 29–38Google Scholar
  5. 5.
    Harris MI (1990) Noninsulin-dependent diabetes mellitus in Black and White Americans. Diab Metab Rev 6: 71–90Google Scholar
  6. 6.
    Omar MAK, Seedat MA, Dyer RB, Rajput MC, Motala AA (1985) The prevalence of diabetes mellitus in a large group of South African Indians. S Afr Med J 67: 924–926PubMedGoogle Scholar
  7. 7.
    Ramachandran A, Mohan V, Snehalatha C, Viswanathan M (1988) Prevalence of non-insulin-dependent diabetes mellitus in Asian Indian families with a single diabetic parent. Diabetes Res Clin Prac 4: 241–245Google Scholar
  8. 8.
    Zimmet P, Dowse G, Finch C (1990) The epidemiology and natural history of NIDDM — lessons from the South Pacific. Diab Metab Rev 6: 91–124Google Scholar
  9. 9.
    Knowler WC, Pettitt DJ, Saad MF, Bennett PH (1990) Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diab Metab Rev 6: 1–27Google Scholar
  10. 10.
    Rotter JI, Vadheim CM, Rimoin DL (1990) Genetics of diabetes mellitus. In: Rifkin H, Porte DJr (eds) Diabetes mellitus. Elsevier, New York, pp 378–413Google Scholar
  11. 11.
    Cox NJ, Bell GI (1989) Disease associations. Diabetes 38: 947–50PubMedGoogle Scholar
  12. 12.
    Magnuson MA (1990) Glucokinase gene structure. Diabetes 39: 523–527PubMedGoogle Scholar
  13. 13.
    Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes. Diabetes 39: 647–652PubMedGoogle Scholar
  14. 14.
    Tanizawa Y, Koranyi LI, Welling CM, Permutt MA (1991) Human liver glucokinase gene: cloning and sequence determination of two alternatively spliced cDNAs. Proc Natl Acad Sci USA 88: 7294–7297PubMedGoogle Scholar
  15. 15.
    Matsutani A, Janssen R, Donis-Keller H, Permutt MA (1992) A polymorphic (CA)n repeat element maps the human glucokinase gene to chromosome 7p. Genomics 12: 319–325PubMedGoogle Scholar
  16. 16.
    WHO Study Group (1985) Diabetes Mellitus. Geneva, World Health Organization. (Tech. Rep. Ser., No. 727)Google Scholar
  17. 17.
    Todd JA, Bell JI, McDevitt HO (1987) HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604CrossRefPubMedGoogle Scholar
  18. 18.
    Gao X, Serjeantson SW (1991) Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania. Immunogenetics 34: 401–408PubMedGoogle Scholar
  19. 19.
    Grizzle JE, Starmer CF, Koch GG (1969) Analysis of categorical data by linear models. Biometrics 25: 489–504PubMedGoogle Scholar
  20. 20.
    Litt M, Luty JA (1989) A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac actin gene. Am J Hum Genet 44: 397–401PubMedGoogle Scholar
  21. 21.
    Weber JL, May PE (1989) Abundant class of human polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388–396PubMedGoogle Scholar
  22. 22.
    Weber JL (1990) Informativeness of human (dC-dA)n(dG-dT)n polymorphism. Genomics 7: 524–530PubMedGoogle Scholar
  23. 23.
    Serjeantson SW, Owerbach D, Zimmet P, Nerup J, Thoma K (1983) Genetics of diabetes in Nauru: effects of foreign admixture. HLA antigens and the insulin-gene-linked polymorphism. Diabetologia 25: 13–17CrossRefPubMedGoogle Scholar
  24. 24.
    Zimmet P (1982) Type 2 (non-insulin-dependent) diabetes — An epidemiological overview. Diabetologia 22: 399–411CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • K. C. Chiu
    • 1
  • M. A. Province
    • 2
  • G. K. Dowse
    • 3
  • P. Z. Zimmet
    • 3
  • G. Wagner
    • 4
  • S. Serjeantson
    • 4
  • M. A. Permutt
    • 1
  1. 1.Metabolism Division, Department of Internal MedicineWashington University School of MedicineSt. LouisUSA
  2. 2.Division of BiostatisticsWashington University School of MedicineSt. LouisUSA
  3. 3.International Diabetes InstituteCaulfield General Medical CenterCaulfield SouthAustralia
  4. 4.Department of Human Biologythe John Curtin School of Medical ResearchCanberraAustralia

Personalised recommendations